in millions of euros, unless otherwise stated, | |||
for the year ended December 31
|
2024
|
2023
|
|
Revenues
|
Note 5/6
|
5,91 6
|
5,584
|
Cost of revenues
|
Note 5
|
(1 , 6 2 6)
|
(1 , 5 7 6)
|
Gross profit
|
Note 5
|
4,290
|
4,008
|
Sales costs
|
Note 9
|
(9 6 9)
|
(9 2 9)
|
General and administrative
costs
|
Note 10
|
(1, 8 7 0)
|
(1 , 749)
|
Total operating expenses
|
Note 5
|
(2 , 8 3 9)
|
(2 , 6 7 8)
|
Other gains and (losses)
|
Note 11
|
(1 0)
|
(7)
|
Operating profit
|
Note 5
|
1, 4 41
|
1, 32 3
|
Financing income
|
52
|
55
|
|
Financing costs
|
(1 1 4)
|
(82)
|
|
Other finance income and (costs)
|
(3)
|
0
|
|
Total financing results
|
Note 14
|
(6 5)
|
(2 7)
|
Share of profit of equity-accounted
associates, net of tax
|
Note 20
|
2
|
1
|
Profit before tax
|
1, 378
|
1,2 97
|
|
Income tax expense
|
Note 15
|
(2 9 9)
|
(2 9 0)
|
Profit for the year
|
1,07 9
|
1,0 07
|
|
Attributable to: | |||
– Owners of the company
|
1,07 9
|
1,0 07
|
|
– Non-controlling interests
|
Note 16
|
0
|
0
|
Profit for the year
|
1,07 9
|
1,0 07
|
|
Earnings per share (EPS) (€) | |||
Basic EPS
|
Note 7
|
4.5 4
|
4 .1 1
|
Diluted EPS
|
Note 7
|
4. 52
|
4.09
|
in millions of euros, | |||
for the year ended December 31
|
2024
|
2023
|
|
Comprehensive income | |||
Profit for the year
|
1,07 9
|
1,0 07
|
|
Other comprehensive income | |||
Items that are or may be reclassified
subsequently to the
consolidated statement ofprofitorloss:
|
|||
Exchange differences on translation of foreign operations
|
227
|
(1 2 6)
|
|
Exchange differences on translation of equity-accounted | |||
associates
|
Note 20
|
0
|
(1)
|
Recycling of foreign exchange
differences on loss of control
|
Note 8
|
(1)
|
–
|
Gains/(losses) on hedges of
net investments in foreign
operations
|
(1 2)
|
3
|
|
Gains/(losses) on cash flow hedges
|
(1 2)
|
(2 2)
|
|
Net change in fair value of cash flow
hedges reclassified
to
the consolidated statementofprofit
or loss
|
Note 14
|
5
|
15
|
Items that will not be reclassified to the consolidated | |||
statement of profit or loss: | |||
Remeasurement gains/(losses)
on defined benefit plans
|
Note 30
|
(5)
|
(1)
|
Other comprehensive income/(loss) for the year, before tax
|
202
|
(13 2)
|
|
Income tax on items that are or may be reclassified | |||
subsequently to the consolidated
statement ofprofit or loss
|
4
|
0
|
|
Income tax on items that will not
be reclassified to
the
consolidated statement
of profit orloss
|
1
|
0
|
|
Income tax on other comprehensive income
|
Note 22
|
5
|
0
|
Other comprehensive income/(loss) for the year
|
207
|
(13 2)
|
|
Total comprehensive income for the year
|
1, 286
|
875
|
|
Attributable to: | |||
– Owners of the company
|
1, 285
|
875
|
|
– Non-controlling interests
|
1
|
0
|
|
Total comprehensive income for the year
|
1, 286
|
875
|
in millions of euros, for the year ended
December 31
|
2024
|
2023
|
|
Cash flows from operating activities | |||
Profit for the year
|
1,07 9
|
1,0 07
|
|
Adjustments for: | |||
Income tax expense
|
Note 15
|
299
|
290
|
Share of profit of equity-accounted
associates, net of tax
|
Note 20
|
(2)
|
(1)
|
Financing results
|
Note 14
|
65
|
27
|
Amortization, impairment, and depreciation
|
Note 13
|
479
|
445
|
Book (profit)/loss on disposal of operations and non-current | |||
assets
|
(5)
|
(4)
|
|
Fair value changes of contingent considerations
|
Note 11
|
0
|
0
|
Additions to and releases from provisions
|
Note 31
|
14
|
12
|
Appropriation of provisions
|
Note 31
|
(9)
|
(1 0)
|
Changes in employee benefit provisions
|
(2 4)
|
(7)
|
|
Share-based payments
|
Note 12
|
31
|
31
|
Other adjustments
|
5
|
8
|
|
Adjustments excluding autonomous movements in working capital
|
853
|
791
|
|
Inventories
|
9
|
(7)
|
|
Contract assets
|
Note 24
|
16
|
(1 5)
|
Trade and other receivables
|
(4 8)
|
19
|
|
Deferred income
|
Note 24
|
73
|
80
|
Other contract liabilities
|
Note 24
|
(9)
|
0
|
Trade and other payables
|
41
|
21
|
|
Autonomous movements in working capital
|
82
|
98
|
|
Total adjustments
|
935
|
889
|
|
Net cash flows from operations
|
2, 014
|
1,896
|
|
Interest paid (including the interest
portion of lease payments)
|
(9 4)
|
(8 4)
|
|
Interest received
|
52
|
58
|
|
Paid income tax
|
Note 22
|
(3 1 8)
|
(3 2 5)
|
Net cash from operating
activities
|
1,65 4
|
1 , 5 45
|
in millions of euros, for the year ended
December 31
|
2024
|
2023
|
|
Cash flows from investing activities | |||
Capital expenditure
|
Note 17/18
|
(3 1 4)
|
(3 2 4)
|
Proceeds from disposal of
other intangible assets
and
property, plant, and equipment
|
1
|
1
|
|
Acquisition spending, net of cash acquired
|
Note 8
|
(3 3 5)
|
(61)
|
Receipts from divestments,
net of cash disposed
|
Note 8
|
1
|
8
|
Dividends received
|
1
|
0
|
|
Cash used for settlement
of net investment hedges
|
(6)
|
2
|
|
Net cash used in investing
activities
|
(6 5 2)
|
(3 74)
|
|
Cash flows from financing activities | |||
Repayment of loans
|
(7 3 8)
|
(9 2 6)
|
|
Proceeds from new loans
|
1, 2 37
|
977
|
|
Repayment of principal portion
of lease liabilities
|
Note 19
|
(6 2)
|
(6 5)
|
Collateral received/(paid)
|
(2)
|
–
|
|
Repurchased shares
|
Note 32
|
(1,000)
|
(1,000)
|
Dividends paid
|
(5 2 1)
|
(4 6 7)
|
|
Net cash used in financing activities
|
(1 , 0 8 6)
|
(1 , 4 8 1)
|
|
Net cash flows before effect
of exchange differences
|
(8 4)
|
(3 1 0)
|
|
Exchange differences on cash and cash equivalents and bank | |||
overdrafts
|
40
|
(3 1)
|
|
Net change in cash and cash equivalents
and bank overdrafts
|
(4 4)
|
(3 41)
|
|
Cash and cash equivalents
less bank overdrafts at January
1
|
989
|
1,3 30
|
|
Cash and cash equivalents
less bank overdrafts at December
31
|
Note 26
|
945
|
989
|
Add: Bank overdrafts at
December 31
|
Note 26
|
9
|
146
|
Cash and cash equivalents
in the consolidated statement
of
financial position at December
31
|
Note 26
|
954
|
1 ,1 3 5
|
in millions of euros, at December 31
|
2024
|
2023
|
|
Non-current assets | |||
Goodwill
|
Note 17
|
4,7 10
|
4,32 2
|
Intangible assets
other than goodwill
|
Note 17
|
1,735
|
1, 598
|
Property, plant, and equipment
|
Note 18
|
79
|
79
|
Right-of-use assets
|
Note 19
|
214
|
241
|
Investments in equity-accounted
associates
|
Note 20
|
13
|
11
|
Financial assets
|
Note 21
|
5
|
6
|
Non-current contract
assets
|
Note 24
|
18
|
18
|
Non-current other receivables
|
Note 25
|
11
|
14
|
Deferred tax assets
|
Note 22
|
56
|
51
|
Total non-current assets
|
6 , 8 41
|
6,340
|
|
Current assets | |||
Inventories
|
Note 23
|
79
|
84
|
Contract assets
|
Note 24
|
14 8
|
160
|
Trade receivables
|
Note 24
|
1 ,1 2 9
|
1,087
|
Other receivables
|
Note 25
|
265
|
202
|
Current income tax assets
|
Note 22
|
82
|
86
|
Cash and cash equivalents
|
Note 26
|
954
|
1 ,1 3 5
|
Total current assets
|
2,65 7
|
2,75 4
|
|
Total assets
|
9,4 9 8
|
9,0 9 4
|
in millions of euros, at December 31
|
2024
|
2023
|
|
Equity | |||
Issued share capital
|
Note 32
|
29
|
30
|
Share premium reserve
|
87
|
87
|
|
Legal reserves
|
540
|
328
|
|
Treasury shares
|
(47 0)
|
(7 3 4)
|
|
Retained earnings
|
1, 3 59
|
2 ,038
|
|
Equity attributable
to the owners of the company
|
Note 46
|
1, 5 45
|
1 , 749
|
Non-controlling interests
|
Note 16
|
0
|
0
|
Total equity
|
1, 5 45
|
1, 74 9
|
|
Non-current liabilities | |||
Bonds
|
3 , 3 24
|
2,72 3
|
|
Private placements
|
122
|
127
|
|
Lease liabilities
|
179
|
209
|
|
Other long-term debt
|
38
|
27
|
|
Total long-term debt
|
Note 28
|
3 ,66 3
|
3,086
|
Deferred tax liabilities
|
Note 22
|
3 24
|
281
|
Employee benefits
|
Note 30
|
67
|
81
|
Provisions
|
Note 31
|
5
|
5
|
Non-current deferred income
|
Note 24
|
110
|
10 2
|
Total non-current liabilities
|
4 ,1 6 9
|
3,555
|
|
Current liabilities | |||
Deferred income
|
Note 24
|
2,054
|
1, 899
|
Other contract liabilities
|
Note 24
|
76
|
86
|
Trade and other payables
|
Note 27
|
1,087
|
997
|
Current income tax liabilities
|
Note 22
|
117
|
128
|
Short-term provisions
|
Note 31
|
28
|
21
|
Borrowings and bank overdrafts
|
Note 28
|
359
|
196
|
Short-term bonds
|
Note 28
|
–
|
400
|
Short-term lease liabilities
|
Note 28
|
63
|
63
|
Total current liabilities
|
3,784
|
3 ,790
|
|
Total liabilities
|
7, 9 5 3
|
7, 3 4 5
|
|
Total equity and liabilities
|
9, 49 8
|
9, 0 9 4
|
Non- | ||||||||||
Legal reserve | Hedge | Translation | Treasury | Retained | Shareholders’ | controlling | ||||
participations | reserve | reserve | shares | earnings | equity |
interests
|
Total equity
|
|||
Balance at January 1, 2023
|
31
|
87
|
120
|
(1 0 6)
|
452
|
(7 3 5)
|
2 , 4 61
|
2, 310
|
0
|
2 , 3 10
|
Profit for the year
|
1,0 07
|
1,0 07
|
0
|
1,0 07
|
||||||
Other comprehensive income/(loss) for the year
|
(4)
|
(1 2 7)
|
(1)
|
(1 3 2)
|
0
|
(13 2)
|
||||
Total comprehensive income/(loss) for theyear
|
(4)
|
(1 2 7)
|
1,006
|
875
|
0
|
875
|
||||
Transactions with owners of the company, recognized directly | ||||||||||
in equity: | ||||||||||
Share-based payments
|
31
|
31
|
31
|
|||||||
Cancelation of shares
|
(1)
|
947
|
(9 4 6)
|
0
|
0
|
|||||
Release LTIP shares
|
54
|
(5 4)
|
0
|
0
|
||||||
Final cash dividend 2022
|
(2 9 1)
|
(2 9 1)
|
0
|
(2 9 1)
|
||||||
Interim cash dividend 2023
|
(1 7 6)
|
(17 6)
|
(1 7 6)
|
|||||||
Repurchased shares
|
(1,000)
|
(1,000)
|
(1,000)
|
|||||||
Other movements
|
(7)
|
7
|
0
|
0
|
||||||
Balance at December 31, 2023
|
30
|
87
|
113
|
(1 1 0)
|
325
|
(7 3 4)
|
2,03 8
|
1 , 74 9
|
0
|
1 , 74 9
|
Balance at January 1, 2024
|
30
|
87
|
113
|
(1 1 0)
|
325
|
(7 3 4)
|
2,03 8
|
1 , 74 9
|
0
|
1 , 74 9
|
Profit for the year
|
1,07 9
|
1,07 9
|
0
|
1 ,07 9
|
||||||
Other comprehensive income/(loss) for the year
|
(1 5)
|
225
|
0
|
(4)
|
206
|
1
|
207
|
|||
Total comprehensive income for theyear
|
(1 5)
|
225
|
0
|
1,075
|
1,28 5
|
1
|
1, 286
|
|||
Transactions with owners of the company, recognized directly | ||||||||||
in equity: | ||||||||||
Share-based payments
|
31
|
31
|
31
|
|||||||
Cancelation of shares
|
(1)
|
1 ,1 8 7
|
(1 ,1 8 6)
|
0
|
0
|
|||||
Release LTIP shares
|
77
|
(77)
|
0
|
0
|
||||||
Final cash dividend 2023
|
(3 24)
|
(3 24)
|
(1)
|
(3 2 5)
|
||||||
Interim cash dividend 2024
|
(1 9 6)
|
(19 6)
|
(1 9 6)
|
|||||||
Repurchased shares
|
(1,000)
|
(1,000)
|
(1,000)
|
|||||||
Other movements
|
2
|
0
|
(2)
|
0
|
0
|
|||||
Balance at December 31, 2024
|
29
|
87
|
115
|
(1 2 5)
|
550
|
(4 7 0)
|
1,3 59
|
1, 5 45
|
0
|
1,5 45
|
The group maintains operations across the U.S. & Canada, Europe, Asia Pacific, and other |
Main currency exchange rates | ||
rates to the euro
|
2024
|
2023
|
U.S. dollar (average)
|
1.08
|
1.08
|
U.S. dollar (at December 31)
|
1.04
|
1.11
|
Note 5 – Segment reporting | ||||||||||||||
Financial & | ||||||||||||||
Tax & | Corporate | Legal & | Corporate | |||||||||||
in millions of euros, unless otherwise
stated
|
Health
|
Accounting | Compliance | Regulatory |
Performance & ESG
|
Corporate
*
|
Total | |||||||
reporting by segment
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
Revenues from contracts
with third parties
|
1,584
|
1,508
|
1,561
|
1,466
|
1,105
|
1,052
|
946
|
875
|
720
|
683
|
–
|
–
|
5,916
|
5,584
|
Cost of revenues
|
(479)
|
(460)
|
(421)
|
(399)
|
(255)
|
(247)
|
(257)
|
(257)
|
(214)
|
(213)
|
–
|
–
|
(1,626)
|
(1,576)
|
Gross profit
|
1,105
|
1,048
|
1,140
|
1,067
|
850
|
805
|
689
|
618
|
506
|
470
|
0
|
0
|
4,290
|
4,008
|
Sales costs
|
(237)
|
(237)
|
(227)
|
(217)
|
(138)
|
(134)
|
(162)
|
(148)
|
(205)
|
(193)
|
–
|
–
|
(969)
|
(929)
|
General and administrative
costs
|
(424)
|
(401)
|
(413)
|
(388)
|
(297)
|
(286)
|
(378)
|
(358)
|
(289)
|
(250)
|
(69)
|
(66)
|
(1,870)
|
(1,749)
|
Total operating expenses
|
(661)
|
(638)
|
(640)
|
(605)
|
(435)
|
(420)
|
(540)
|
(506)
|
(494)
|
(443)
|
(69)
|
(66)
|
(2,839)
|
(2,678)
|
Other gains and (losses)
|
(4)
|
(4)
|
(3)
|
(2)
|
0
|
(2)
|
(4)
|
2
|
1
|
(1)
|
–
|
–
|
(10)
|
(7)
|
Operating profit
|
440
|
406
|
497
|
460
|
415
|
383
|
145
|
114
|
13
|
26
|
(69)
|
(66)
|
1,441
|
1,323
|
Amortization of acquired
identifiable intangible
assets
|
34
|
44
|
19
|
17
|
18
|
18
|
27
|
26
|
49
|
41
|
–
|
–
|
147
|
146
|
Impairment of goodwill
|
2
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
2
|
0
|
Non-benchmark items in operating
profit
|
4
|
4
|
3
|
2
|
0
|
2
|
4
|
(2)
|
(1)
|
1
|
–
|
–
|
10
|
7
|
Adjusted operating profit
|
480
|
454
|
519
|
479
|
433
|
403
|
176
|
138
|
61
|
68
|
(69)
|
(66)
|
1,600
|
1,476
|
Amortization of other
intangible assets
and depreciation of PPE and
right-of-use assets
|
(47)
|
(47)
|
(80)
|
(77)
|
(43)
|
(46)
|
(64)
|
(62)
|
(73)
|
(62)
|
0
|
0
|
(307)
|
(294)
|
Impairment of other intangible
assets, PPE, and right-of-use
assets
|
(13)
|
0
|
(4)
|
(2)
|
(4)
|
0
|
(2)
|
(1)
|
0
|
(2)
|
–
|
–
|
(23)
|
(5)
|
Goodwill and acquired identifiable
intangible assets
at December 31
|
1,300
|
1,260
|
1,656
|
1,284
|
1,210
|
1,159
|
755
|
725
|
727
|
766
|
–
|
–
|
5,648
|
5,194
|
Net capital expenditure
|
43
|
49
|
68
|
74
|
54
|
58
|
53
|
58
|
95
|
84
|
0
|
0
|
313
|
323
|
Number of FTEs at December 31
|
3,401
|
3,333
|
7,159
|
7,276
|
3,030
|
3,056
|
4,147
|
4,033
|
3,315
|
3,215
|
148
|
143
|
21,200
|
21,056
|
Total non-current assets per geographic region | ||||
2024 | 2023 | |||
in millions of euros, unless otherwise stated | % | % | ||
The Netherlands
|
703
|
11
|
715
|
11
|
Europe (excluding the Netherlands)
|
1,642
|
24
|
1,302
|
21
|
U.S. and Canada
|
4,352
|
64
|
4,176
|
67
|
Asia Pacific
|
71
|
1
|
76
|
1
|
Rest of World
|
17
|
0
|
20
|
0
|
Total
|
6,785
|
100
|
6,289
|
100
|
Note 6 – Revenues | ||
2024
|
2023
|
|
Revenues from contracts
with third parties
|
5,916
|
5,584
|
Revenues by recognition pattern and contract length | Tax & | Financial & Corporate | Legal & | Corporate | ||||||||
Health | Accounting | Compliance | Regulatory |
Performance & ESG
|
Total
|
|||||||
reporting per segment
|
2024
|
2023
*
|
2024
|
2023
*
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
*
|
Revenue by recognition pattern | ||||||||||||
At a point in time recognition
|
259
|
253
|
197
|
193
|
379
|
366
|
252
|
246
|
70
|
103
|
1,157
|
1,161
|
Over time recognition
|
1,325
|
1,255
|
1,364
|
1,273
|
726
|
686
|
694
|
629
|
650
|
580
|
4,759
|
4,423
|
Revenues from contracts
with third parties
|
1,584
|
1,508
|
1,561
|
1,466
|
1,105
|
1,052
|
946
|
875
|
720
|
683
|
5,916
|
5,584
|
Revenue by contract length | ||||||||||||
Contracts one year or less
|
1,010
|
936
|
1,404
|
1,304
|
887
|
844
|
685
|
644
|
339
|
354
|
4,325
|
4,082
|
Multi-year contracts
|
574
|
572
|
157
|
162
|
218
|
208
|
261
|
231
|
381
|
329
|
1,591
|
1,502
|
Revenues from contracts
with third parties
|
1,584
|
1,508
|
1,561
|
1,466
|
1,105
|
1,052
|
946
|
875
|
720
|
683
|
5,916
|
5,584
|
Restated for certain reclassifications. See Note 1 – General and basis of preparation. | ||||||||||||
Revenues by media format | Tax & | Financial & Corporate | Legal & | Corporate | ||||||||
Health | Accounting | Compliance | Regulatory |
Performance & ESG
|
Total
|
|||||||
reporting per segment
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
Digital
|
1,427
|
1,348
|
1,495
|
1,398
|
578
|
558
|
815
|
736
|
720
|
683
|
5,035
|
4,723
|
Services
|
4
|
4
|
34
|
33
|
522
|
488
|
9
|
9
|
0
|
0
|
569
|
534
|
Print
|
153
|
156
|
32
|
35
|
5
|
6
|
122
|
130
|
–
|
–
|
312
|
327
|
Revenues from contracts
with third parties
|
1,584
|
1,508
|
1,561
|
1,466
|
1,105
|
1,052
|
946
|
875
|
720
|
683
|
5,916
|
5,584
|
Recurring/non-recurring revenues | ||||||||||||
Tax & | Financial & Corporate | Legal & | Corporate | |||||||||
Health | Accounting | Compliance | Regulatory |
Performance & ESG
|
Total
|
|||||||
reporting per segment
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
Recurring revenues
|
1,449
|
1,374
|
1,431
|
1,339
|
744
|
704
|
746
|
683
|
498
|
443
|
4,868
|
4,543
|
Non-recurring revenues
|
135
|
134
|
130
|
127
|
361
|
348
|
200
|
192
|
222
|
240
|
1,048
|
1,041
|
Revenues from contracts
with third parties
|
1,584
|
1,508
|
1,561
|
1,466
|
1,105
|
1,052
|
946
|
875
|
720
|
683
|
5,916
|
5,584
|
Revenues by type | ||||
Digital and service subscription
|
4,458
|
2024
|
4,134
|
2023
|
Print subscription
|
125
|
136
|
||
Other recurring
|
285
|
273
|
||
Total recurring revenues
|
4,868
|
4,543
|
||
Print books
|
120
|
120
|
||
Legal Services transactional
|
306
|
283
|
||
Financial Services transactional
|
130
|
128
|
||
Other non-recurring
*
|
492
|
510
|
||
Total non-recurring revenues
|
1,048
|
1,041
|
||
Revenues from contracts
with third parties
|
5,916
|
5,584
|
Revenues per geographic region | ||||
2024 | 2023 | |||
in millions of euros, unless otherwise stated | % | % | ||
The Netherlands
|
248
|
4
|
227
|
4
|
Europe (excluding the Netherlands)
|
1,415
|
24
|
1,342
|
24
|
U.S. and Canada
|
3,791
|
64
|
3,577
|
64
|
Asia Pacific
|
351
|
6
|
345
|
6
|
Rest of World
|
111
|
2
|
93
|
2
|
Revenues from contracts
with third parties
|
5,916
|
100
|
5,584
|
100
|
Profit for the year | ||
2024
|
2023
|
|
Profit for the year attributable
to the owners of the company
(A)
|
1,079
|
1,007
|
Weighted-average number of ordinary shares for the year | |||
in millions of shares, unless otherwise
stated
|
2024
|
2023
|
|
Outstanding ordinary shares at January 1
|
Note 32
|
248.5
|
257.5
|
Effect of cancelation of shares
|
(2.9)
|
(3.4)
|
|
Effect of repurchased shares
|
(8.1)
|
(9.2)
|
|
Weighted-average number of ordinary
shares (B)
|
237.5
|
244.9
|
|
Basic EPS (A/B) (€)
|
4.54
|
4.11
|
Diluted weighted-average number of ordinary shares for the year | ||
in millions of shares, unless otherwise
stated
|
2024
|
2023
|
Weighted-average number of ordinary
shares (B)
|
237.5
|
244.9
|
Effect of long-term incentive
plan (LTIP) and restricted
stock units (RSU)
|
0.9
|
1.1
|
Diluted weighted-average
number of ordinary shares (C)
|
238.4
|
246.0
|
Diluted EPS (A/C) (€)
|
4.52
|
4.09
|
Acquisitions | |||||
2024 | 2023 | ||||
Carrying | Fair value | Recognized | Recognized | ||
amounts | adjustments | values | values | ||
Consideration payable in cash
|
357
|
60
|
|||
Deferred and contingent | |||||
considerations at fair value: | |||||
Non-current
|
–
|
2
|
|||
Current
|
0
|
2
|
|||
Total consideration
|
357
|
64
|
|||
Intangible assets other
than goodwill
|
Note 17
|
0
|
185
|
185
|
51
|
Other non-current assets
|
Note 19
|
4
|
4
|
0
|
|
Current assets
|
33
|
33
|
7
|
||
Current liabilities
|
(12)
|
(12)
|
(9)
|
||
Non-current liabilities
|
Note 28
|
(4)
|
(4)
|
(1)
|
|
Employee benefits
|
(1)
|
(1)
|
–
|
||
Deferred tax
assets/(liabilities)
|
0
|
(45)
|
(45)
|
(10)
|
|
Fair value of net identifiable assets
|
20
|
140
|
160
|
38
|
|
Goodwill on acquisitions
|
Note 17
|
197
|
26
|
||
Cash effect of acquisitions: | |||||
Consideration payable in cash
|
357
|
60
|
|||
Cash acquired
|
(25)
|
(2)
|
|||
Deferred and contingent | |||||
considerations paid
|
Note 29
|
3
|
3
|
||
Acquisition spending, net of cash | |||||
acquired
|
335
|
61
|
Contribution of 2024 acquisitions | ||||
Adjusted | FTEs at | |||
operating | Profit for | December | ||
in millions of euros, unless otherwise
stated
|
Revenues
|
profit | the year | 31, 2024 |
Totals excluding the impact
of 2024 acquisitions
|
5,901
|
1,597
|
1,079
|
21,076
|
Contribution of 2024 acquisitions
|
15
|
3
|
0
|
124
|
Totals for the year 2024
|
5,916
|
1,600
|
1,079
|
21,200
|
Pro forma contribution of 2024 acquisitions for
the period January 1, 2024, up to acquisition
date
|
||||
(unaudited)
|
28
|
7
|
(1)
|
|
Pro forma totals for the year 2024
|
5,944
|
1,607
|
1,078
|
21,200
|
Divestment-related results on operations and financial assets | |||
2024
|
2023
|
||
Divestment of operations: | |||
Consideration receivable
in cash
|
1
|
5
|
|
Deferred divestment consideration receivable
|
0
|
–
|
|
Consideration receivable
|
1
|
5
|
|
Intangible assets
|
Note 17
|
3
|
–
|
Other non-current assets
|
0
|
–
|
|
Current assets (including assets
held for sale)
|
3
|
–
|
|
Current liabilities (including
liabilities held for sale)
|
(6)
|
–
|
|
Deferred tax
assets/(liabilities)
|
(1)
|
1
|
|
Net identifiable assets/(liabilities)
|
(1)
|
1
|
|
Reclassification
of foreign exchange differences
on loss of control to
profit or loss, previously recognized in other comprehensive income
|
1
|
–
|
|
Book profit/(loss) on divestments
of operations
|
3
|
4
|
|
Divestment-related costs
|
(5)
|
0
|
|
Restructuring of stranded costs following
divestments
|
Note 31
|
(1)
|
–
|
Divestment-related results
included in other gains and (losses)
|
Note 11
|
(3)
|
4
|
Divestment of financial assets | |||
Consideration receivable
in cash
|
–
|
3
|
|
Carrying value of financial assets
|
–
|
0
|
|
Divestment-related results
included in total financing results
|
Note 14
|
0
|
3
|
Cash effect of divestments: | |||
Consideration receivable
in cash
|
1
|
8
|
|
Cash included in divested
operations
|
0
|
–
|
|
Receipts from divestments,
net of cash disposed
|
1
|
8
|
Note 9 – Sales costs | |||
2024
|
2023
|
||
Marketing and promotion costs
|
258
|
253
|
|
Sales-related costs – sales
commissions directly expensed
|
171
|
157
|
|
Sales-related costs – amortization
of capitalized sales commissions
|
Note 24
|
29
|
29
|
Other sales-related costs
|
407
|
383
|
|
Customer support costs
|
86
|
84
|
|
Additions to and releases from loss allowances on trade receivables | |||
and unbilled revenues
|
Note 24
|
18
|
23
|
Total
|
969
|
929
|
Note 10 – General and administrative costs | |||
2024
|
2023
|
||
Research, development, and editorial costs
|
688
|
591
|
|
General and administrative
operating expenses
|
1,033
|
1,012
|
|
Amortization and impairment of acquired identifiable | |||
intangible assets and goodwill
|
Note 13
|
149
|
146
|
Total
|
1,870
|
1,749
|
Note 11 – Other gains and (losses) | |||
2024
|
2023
|
||
Acquisition-related costs
|
Note 8
|
(7)
|
(7)
|
Additions to acquisition integration provisions
|
Note 31
|
0
|
(4)
|
Fair value changes of contingent considerations
|
Note 29
|
0
|
0
|
Divestment-related results
|
Note 8
|
(3)
|
4
|
Total
|
(10)
|
(7)
|
Note 12 – Employee benefit expenses | |||
in millions of euros, unless otherwise
stated
|
2024
|
2023
|
|
Salaries and wages and other
benefits
|
1,963
|
1,848
|
|
Social security charges
|
167
|
161
|
|
Medical cost benefits
|
102
|
101
|
|
Expenses related
to defined contribution
plans
|
105
|
96
|
|
Expenses related
to defined benefit plans
|
Note 30
|
(10)
|
16
|
Equity-settled share-based payments
|
Note 33
|
31
|
31
|
Total
|
2,358
|
2,253
|
Employees | ||
Headcount at December 31
|
21,635
|
21,438
|
Thereof employed in the Netherlands
|
1,180
|
1,176
|
In full-time equivalents at December
31
|
21,200
|
21,056
|
In full-time equivalents average
per annum
|
21,167
|
20,810
|
Note 13 – Amortization, impairment, and depreciation | |||
2024
|
2023
|
||
Amortization of acquired
identifiable intangible assets
|
Note 17
|
147
|
146
|
Impairment of goodwill
|
Note 17
|
2
|
–
|
Amortization of other
intangible assets
|
Note 17
|
223
|
204
|
Impairment of other intangible
assets
|
Note 17
|
22
|
5
|
Depreciation of property, plant, and equipment
|
Note 18
|
24
|
23
|
Impairment of property, plant,
and equipment
|
Note 18
|
1
|
0
|
Depreciation of right-of-use
assets
|
Note 19
|
60
|
67
|
Total
|
479
|
445
|
Note 14 – Financing results | |||
Financing income |
2024
|
2023
|
|
Interest income for financial assets measured at amortized cost: | |||
Interest income on short-term bank deposits
|
45
|
50
|
|
Interest income on bank balances
and other
Other financing income:
|
7
|
5
|
|
Derivatives – foreign
exchange contracts,
not qualifying as hedge
|
0
|
0
|
|
Total financing income
|
52
|
55
|
|
Financing costs | |||
Interest expense for financial liabilities measured at amortized cost: | |||
Interest expense on Euro Commercial Paper program and bank | |||
borrowings
|
(6)
|
(3)
|
|
Interest expense on
bonds and private placements
|
(80)
|
(68)
|
|
Amortization of fee expense
for debt instruments
|
Note 28
|
(3)
|
(3)
|
Interest expense on
bank overdrafts and other
Other financing expense:
|
(4)
|
(3)
|
|
Unwinding of discount of lease liabilities
|
Note 28
|
(8)
|
(9)
|
Net foreign exchange gains/(losses)
|
(9)
|
7
|
|
Items in hedge relationships: | |||
Interest rate swaps
|
(4)
|
(3)
|
|
Foreign exchange gains/(losses)
on loans subject to cash flow hedge
|
5
|
15
|
|
Net change in fair value of cash flow
hedges reclassified
from other
comprehensive income
|
(5)
|
(15)
|
|
Total financing costs
|
(114)
|
(82)
|
|
Net financing results
|
(62)
|
(27)
|
|
Other finance income and (costs) | |||
Divestment-related results
on financial assets
|
Note 8
|
–
|
3
|
Fair value changes of financial assets
|
–
|
0
|
|
Financing component employee benefits
|
Note 30
|
(3)
|
(3)
|
Total other finance income and (costs)
|
(3)
|
0
|
|
Total financing results
|
(65)
|
(27)
|
Note 15 – Income tax expense | |||||
2024
|
2023
|
||||
Current income tax expense
|
323
|
300
|
|||
Adjustments previous years
|
(12)
|
(2)
|
|||
Deferred tax expense: | |||||
Changes in tax rates
|
0
|
0
|
|||
Origination and reversal
of temporary differences
|
(12)
|
(8)
|
|||
Movements in deferred
tax assets and
liabilities
|
Note 22
|
(12)
|
(8)
|
||
Total
|
Note 22
|
299
|
290
|
2024
|
2023
|
|||
in millions of euros, unless otherwise
stated
|
%
|
%
|
||
Profit before tax
|
1,378
|
1,297
|
||
Income tax expense at the Dutch statutory income | ||||
tax rate
|
25.8
|
356
|
25.8
|
335
|
Tax effect of: | ||||
Rate differential
|
(3.1)
|
(42)
|
(2.9)
|
(38)
|
Tax incentives, exempt
income, and divestments
|
(2.0)
|
(27)
|
(0.8)
|
(10)
|
Recognized and unrecognized
tax losses
|
0.5
|
6
|
0.0
|
0
|
Adjustments previous years
|
(0.8)
|
(12)
|
(0.1)
|
(2)
|
Changes in income tax rates
|
0.0
|
0
|
0.0
|
0
|
Other taxes
|
1.1
|
15
|
0.9
|
11
|
Pillar Two Global Minimum Tax
|
0.3
|
5
|
–
|
–
|
Non-deductible costs and other items
|
(0.1)
|
(2)
|
(0.5)
|
(6)
|
Total
|
21.7
|
299
|
22.4
|
290
|
ownership in %
|
2024
|
2023
|
Akadémiai Kiadó Kft. (Budapest, Hungary)
|
74
|
74
|
Note 17 – Goodwill and intangible assets other than goodwill | ||||||||||
Acquired | ||||||||||
identifiable | Other | |||||||||
Customer | Technology | intangible | intangible | |||||||
Position at January 1 | Goodwill | relationships |
and content
|
Brand names
|
Other
|
assets |
assets
|
2024
|
2023
|
|
Cost value
|
4,322
|
1,105
|
690
|
457
|
3
|
2,255
|
2,083
|
8,660
|
8,844
|
|
Accumulated amortization
and impairment
|
–
|
(603)
|
(377)
|
(400)
|
(3)
|
(1,383)
|
(1,357)
|
(2,740)
|
(2,802)
|
|
Book value at January 1
|
4,322
|
502
|
313
|
57
|
0
|
872
|
726
|
5,920
|
6,042
|
|
Movements | ||||||||||
Investments
|
–
|
–
|
–
|
–
|
–
|
0
|
293
|
293
|
298
|
|
Acquired through business combinations
|
Note 8
|
197
|
112
|
64
|
9
|
–
|
185
|
0
|
382
|
77
|
Divestment of operations
|
Note 8
|
0
|
–
|
–
|
–
|
–
|
0
|
(3)
|
(3)
|
–
|
Disposal of assets
|
–
|
–
|
–
|
–
|
–
|
0
|
0
|
0
|
0
|
|
Net expenditures
|
197
|
112
|
64
|
9
|
0
|
185
|
290
|
672
|
375
|
|
Amortization
|
Note 13
|
–
|
(80)
|
(58)
|
(9)
|
0
|
(147)
|
(223)
|
(370)
|
(350)
|
Impairment
|
Note 13
|
(2)
|
–
|
–
|
–
|
–
|
0
|
(22)
|
(24)
|
(5)
|
Reclassifications
|
(1)
|
–
|
–
|
–
|
–
|
0
|
–
|
(1)
|
(3)
|
|
Foreign exchange differences
|
194
|
16
|
11
|
1
|
0
|
28
|
26
|
248
|
(139)
|
|
Total movements
|
388
|
48
|
17
|
1
|
0
|
66
|
71
|
525
|
(122)
|
|
Position at December 31 | ||||||||||
Cost value
|
4,710
|
1,243
|
776
|
487
|
0
|
2,506
|
2,341
|
9,557
|
8,660
|
|
Accumulated amortization
and impairment
|
–
|
(693)
|
(446)
|
(429)
|
0
|
(1,568)
|
(1,544)
|
(3,112)
|
(2,740)
|
|
Book value at December
31
|
4,710
|
550
|
330
|
58
|
0
|
938
|
797
|
6,445
|
5,920
|
Carrying amounts of goodwill and acquired identifiable intangible assets per operating | ||||
segment | ||||
Acquired | ||||
identifiable | ||||
Goodwill |
intangible assets
|
2024
|
2023
|
|
Health
|
1,177
|
123
|
1,300
|
1,260
|
Tax & Accounting
|
1,401
|
255
|
1,656
|
1,284
|
Financial & Corporate Compliance
|
1,046
|
164
|
1,210
|
1,159
|
Legal & Regulatory
|
614
|
141
|
755
|
725
|
Corporate Performance & ESG
|
472
|
255
|
727
|
766
|
Total
|
4,710
|
938
|
5,648
|
5,194
|
2024
|
2023
|
|
Risk-free rate United
States (in %)
|
4.9
|
4.2
|
Risk-free rate Europe (in %)
|
3.0
|
2.8
|
Market risk premium United States
(in %)
|
5.0
|
5.5
|
Market risk premium Europe (in %)
|
5.5
|
6.0
|
Tax rate United States
(in %)
|
26.0
|
26.0
|
Tax rate Europe (in %)
|
25.8
|
25.8
|
Re-levered beta
|
0.84
|
0.80
|
Applied | Allowed change (in basis points) | ||||
weighted- | Decrease | Allocated | |||
2024 sensitivity per group of CGUs | average | Decline | Increase | in adjusted | goodwill at |
in millions of euros, unless otherwise | growth | in growth | in discount | operating | December |
stated | rate | rate | rate | profit margin | 31, 2024 |
Health
|
2.1%
|
>300
|
>300
|
>300
|
1,177
|
Tax & Accounting
|
2.1%
|
>300
|
>300
|
>300
|
1,401
|
Financial & Corporate Compliance
|
2.1%
|
>300
|
>300
|
>300
|
1,046
|
Legal & Regulatory
|
2.1%
|
>300
|
>300
|
>300
|
614
|
Corporate Performance & ESG
|
2.1%
|
>300
|
>300
|
>300
|
472
|
Total
|
2.1%
|
4,710
|
Applied | Allowed change (in basis points) | ||||
weighted- | Decrease | Allocated | |||
2023 sensitivity per group of CGUs | average | Decline | Increase | in adjusted | goodwill at |
in millions of euros, unless otherwise | growth | in growth | in discount | operating | December |
stated | rate | rate | rate | profit margin | 31, 2023 |
Health
|
2.3%
|
>300
|
>300
|
>300
|
1,111
|
Tax & Accounting
|
2.2%
|
>300
|
>300
|
>300
|
1,188
|
Financial & Corporate Compliance
|
2.3%
|
>300
|
>300
|
>300
|
987
|
Legal & Regulatory
|
2.3%
|
>300
|
>300
|
>300
|
573
|
Corporate Performance & ESG
|
2.2%
|
>300
|
>300
|
>300
|
463
|
Total
|
2.3%
|
4,322
|
2024
|
2023
|
||
Goodwill
|
2
|
–
|
|
Other intangible assets
|
22
|
5
|
|
Total
|
Note 13
|
24
|
5
|
Land and | |||||
Position at January 1 |
buildings
|
Other PPE
|
2024
|
2023
|
|
Cost value
|
92
|
176
|
268
|
317
|
|
Accumulated depreciation and
impairment
|
(60)
|
(129)
|
(189)
|
(238)
|
|
Book value at January 1
|
32
|
47
|
79
|
79
|
|
Movements | |||||
Investments
|
2
|
19
|
21
|
26
|
|
Acquired through business | |||||
combinations
|
0
|
–
|
0
|
0
|
|
Disposal of assets
|
0
|
(1)
|
(1)
|
(1)
|
|
Net expenditures
|
2
|
18
|
20
|
25
|
|
Depreciation
|
Note 13
|
(5)
|
(19)
|
(24)
|
(23)
|
Impairment
|
Note 13
|
(1)
|
0
|
(1)
|
0
|
Foreign exchange differences
|
2
|
3
|
5
|
(2)
|
|
Total movements
|
(2)
|
2
|
0
|
0
|
|
Position at December 31 | |||||
Cost value
|
90
|
179
|
269
|
268
|
|
Accumulated depreciation and
impairment
|
(60)
|
(130)
|
(190)
|
(189)
|
|
Book value at December 31
|
30
|
49
|
79
|
79
|
Movement schedule of right-of-use assets | |||||
Other | |||||
Position at January 1 | Real estate |
leases
|
2024
|
2023
|
|
Cost value
|
575
|
48
|
623
|
685
|
|
Accumulated depreciation and impairment
|
(353)
|
(29)
|
(382)
|
(402)
|
|
Book value at January 1
|
222
|
19
|
241
|
283
|
|
Movements | |||||
Additions from new leases
|
6
|
17
|
23
|
27
|
|
Acquired through business combinations
|
3
|
1
|
4
|
0
|
|
Additions from contract modifications and
reassessment of options
|
13
|
1
|
14
|
8
|
|
Other movements from contract | |||||
modifications and reassessment of options
|
(15)
|
(1)
|
(16)
|
(4)
|
|
Net additions
|
7
|
18
|
25
|
31
|
|
Depreciation
|
Note 13
|
(47)
|
(13)
|
(60)
|
(67)
|
Foreign exchange differences
|
7
|
1
|
8
|
(6)
|
|
Total movements
|
(33)
|
6
|
(27)
|
(42)
|
|
Position at December 31 | |||||
Cost value
|
556
|
53
|
609
|
623
|
|
Accumulated depreciation and impairment
|
(367)
|
(28)
|
(395)
|
(382)
|
|
Book value at December 31
|
189
|
25
|
214
|
241
|
Contractual maturities of lease liabilities | |||
2024
|
2023
|
||
Within one year
|
65
|
65
|
|
Between one and two years
|
53
|
55
|
|
Between two and three
years
|
44
|
44
|
|
Between three and four years
|
34
|
36
|
|
Between four and five years
|
24
|
30
|
|
Between five and ten years
|
48
|
72
|
|
Ten years and more
|
–
|
1
|
|
Effect of discounting
|
(26)
|
(31)
|
|
Total lease liabilities at
December 31
|
Note 28
|
242
|
272
|
Cash outflow for leases | ||
2024
|
2023
|
|
Interest portion of lease
payments
|
8
|
9
|
Repayment of principal portion
of lease liabilities
|
62
|
65
|
Total
|
70
|
74
|
ownership in %
|
2024
|
2023
|
Haoyisheng (Beijing, China)
|
22
|
22
|
Movement schedule of equity-accounted associates | ||
2024
|
2023
|
|
Position at January 1
|
11
|
11
|
Share of profit of equity-accounted
associates, net
of tax
|
2
|
1
|
Foreign exchange differences
|
0
|
(1)
|
Position at December 31
|
13
|
11
|
Total equity-accounted | ||||
associates
|
Group’s share
|
|||
2024
|
2023
|
2024
|
2023
|
|
Total assets
|
43
|
38
|
9
|
8
|
Total liabilities
|
26
|
22
|
5
|
5
|
Total equity
|
17
|
16
|
4
|
3
|
Revenues
|
26
|
30
|
6
|
6
|
Net profit for the year
|
2
|
3
|
2
|
1
|
Note 21 – Financial assets | ||
2024
|
2023
|
|
Financial assets at fair value
through profit or loss
|
0
|
0
|
Finance lease receivables
|
1
|
1
|
Other non-current financial assets
|
4
|
5
|
Total
|
5
|
6
|
Deferred tax assets and liabilities | ||||
temporary differences arising from:
|
Assets
|
Liabilities
|
2024
|
2023
|
Intangible assets
|
6
|
(430)
|
(424)
|
(392)
|
Property, plant, and equipment, right-of-use | ||||
assets, and lease liabilities
|
76
|
(57)
|
19
|
21
|
Employee benefits
|
42
|
–
|
42
|
37
|
Tax value of loss carry-forwards
recognized
|
17
|
–
|
17
|
23
|
Other items
|
106
|
(28)
|
78
|
81
|
Total before set-off of tax
|
247
|
(515)
|
(268)
|
(230)
|
Set-off of tax
|
(191)
|
191
|
0
|
0
|
Position at December 31
|
56
|
(324)
|
(268)
|
(230)
|
Movements in temporary differences 2024 | ||||||
Recognized | Recognized in | |||||
Balance at | in profit or | equity and OCI | Foreign | Balance at | ||
January 1, | Acquisitions/ | loss | comprehensive | exchange | December | |
2024 | divestments | (Note 15) | income | differences | 31, 2024 | |
Intangible assets
|
(392)
|
(44)
|
31
|
–
|
(19)
|
(424)
|
PPE, right-of-use | ||||||
assets, and lease | ||||||
liabilities
|
21
|
–
|
(2)
|
–
|
0
|
19
|
Employee benefits
|
37
|
–
|
1
|
1
|
3
|
42
|
Tax value of loss carry-
forwards recognized
|
23
|
–
|
(8)
|
–
|
2
|
17
|
Other items
|
81
|
(1)
|
(10)
|
4
|
4
|
78
|
Total
|
(230)
|
(45)
|
12
|
5
|
(10)
|
(268)
|
Movements in temporary differences 2023 | ||||||
Recognized | Recognized in | |||||
Balance at | in profit or | equity and OCI | Foreign | Balance at | ||
January 1, | Acquisitions/ | loss | comprehensive | exchange | December | |
2023 | divestments | (Note 15) | income | differences | 31, 2023 | |
Intangible assets
|
(395)
|
(7)
|
1
|
–
|
9
|
(392)
|
PPE, right-of-use | ||||||
assets, and lease | ||||||
liabilities
|
17
|
–
|
4
|
–
|
0
|
21
|
Employee benefits
|
38
|
–
|
0
|
0
|
(1)
|
37
|
Tax value of loss | ||||||
carry-forwards | ||||||
recognized
|
31
|
–
|
(7)
|
–
|
(1)
|
23
|
Other items
|
72
|
(1)
|
10
|
0
|
0
|
81
|
Total
|
(237)
|
(8)
|
8
|
0
|
7
|
(230)
|
Movements in overall tax position | |||
Position at January 1 |
2024
|
2023
|
|
Current income tax assets
|
86
|
61
|
|
Current income tax liabilities
|
(128)
|
(129)
|
|
Deferred tax assets
|
51
|
62
|
|
Deferred tax liabilities
|
(281)
|
(299)
|
|
Overall tax position
|
(272)
|
(305)
|
|
Movements | |||
Total income tax expense
|
Note 15
|
(299)
|
(290)
|
Deferred tax from acquisitions
and divestments
|
(45)
|
(8)
|
|
Current income tax from acquisitions and divestments
|
0
|
0
|
|
Deferred tax on items recognized
directly in OCI
|
5
|
0
|
|
Paid income tax
|
318
|
325
|
|
Foreign exchange differences
|
(10)
|
6
|
|
Total movements
|
(31)
|
33
|
|
Position at December 31 | |||
Current income tax assets
|
82
|
86
|
|
Current income tax liabilities
|
(117)
|
(128)
|
|
Deferred tax assets
|
56
|
51
|
|
Deferred tax liabilities
|
(324)
|
(281)
|
|
Overall tax position
|
(303)
|
(272)
|
Deferred tax on items recognized immediately in other comprehensive income and equity | ||||||
2024
|
2023
|
|||||
Amount | Amount | Amount | Amount | |||
before | net of | before | net of | |||
Exchange differences on translation of
foreign operations, recycling of foreign
|
tax
|
Tax
|
tax |
tax
|
Tax
|
tax |
exchange differences on loss
of control,
and net investment
hedges
|
214
|
0
|
214
|
(124)
|
0
|
(124)
|
Gains/(losses) on cash flow hedges
|
(7)
|
4
|
(3)
|
(7)
|
–
|
(7)
|
Remeasurement gains/(losses) on defined | ||||||
benefit plans
|
(5)
|
1
|
(4)
|
(1)
|
0
|
(1)
|
Recognized in other comprehensive income
|
202
|
5
|
207
|
(132)
|
0
|
(132)
|
Share-based payments
|
31
|
–
|
31
|
31
|
–
|
31
|
Recognized in equity
|
31
|
0
|
31
|
31
|
0
|
31
|
Note 23 – Inventories | ||
2024
|
2023
|
|
Work in progress
|
18
|
27
|
Finished products and trade goods
|
61
|
57
|
Total
|
79
|
84
|
2024
|
2023
|
|
Trade receivables
|
1,129
|
1,087
|
Non-current contract
assets
|
18
|
18
|
Current contract assets
|
148
|
160
|
Non-current deferred income
|
110
|
102
|
Current deferred income
|
2,054
|
1,899
|
Other current contract
liabilities
|
76
|
86
|
Loss allowances | |||
2024
|
2023
|
||
Position at January 1
|
85
|
85
|
|
Additions to loss allowances
|
Note 9
|
35
|
34
|
Releases from loss allowances
|
Note 9
|
(17)
|
(11)
|
Usage of loss allowances
|
(23)
|
(22)
|
|
Foreign exchange differences
|
9
|
(1)
|
|
Position at December 31
|
89
|
85
|
Contract assets | ||||||
Cost to | Cost to | |||||
Unbilled | obtain a | fulfill a | ||||
current and non-current | revenues | contract |
contract
|
2024
|
2023
|
|
Position at January 1
|
97
|
41
|
40
|
178
|
170
|
|
Recognized as revenues
in the year
|
443
|
–
|
–
|
443
|
502
|
|
Newly recognized cost
to fulfill a
contract
|
–
|
–
|
405
|
405
|
519
|
|
Transferred to trade
receivables
|
(462)
|
–
|
(404)
|
(866)
|
(1,007)
|
|
Newly recognized cost
to obtain a
contract
|
–
|
31
|
–
|
31
|
30
|
|
Amortization of capitalized sales | ||||||
commissions
|
Note 9
|
–
|
(29)
|
–
|
(29)
|
(29)
|
Autonomous movements in contract | ||||||
assets
|
(19)
|
2
|
1
|
(16)
|
15
|
|
Acquired through business | ||||||
combinations
|
–
|
–
|
–
|
0
|
0
|
|
Foreign exchange differences
|
2
|
0
|
2
|
4
|
(7)
|
|
Position at December 31
|
80
|
43
|
43
|
166
|
178
|
Deferred income | ||
current and non-current
|
2024
|
2023
|
Position at January 1
|
2,001
|
1,970
|
New and existing contracts
with customers
|
4,668
|
4,300
|
Recognized as revenues from opening balance
|
(1,899)
|
(1,858)
|
Recognized as revenues
in the year on new and existing
contracts
|
(2,650)
|
(2,309)
|
Change in netting against trade
receivables
|
(46)
|
(53)
|
Autonomous movements in deferred income
|
73
|
80
|
Acquired through business combinations
|
4
|
6
|
Divestment of operations
|
(6)
|
–
|
Foreign exchange differences
|
92
|
(55)
|
Position at December 31
|
2,164
|
2,001
|
Other contract liabilities | ||
2024
|
2023
|
|
Position at January 1
|
86
|
88
|
Additions to provision for returns, refunds, and other
|
130
|
121
|
Usage of provision for returns,
refunds, and other
|
(139)
|
(121)
|
Autonomous movements in other contract liabilities
|
(9)
|
0
|
Foreign exchange differences
|
(1)
|
(2)
|
Position at December 31
|
76
|
86
|
Note 25 – Other receivables | |||
2024
|
2023
|
||
Prepaid royalties
|
11
|
14
|
|
Non-current other receivables
|
11
|
14
|
|
Prepaid royalties
|
70
|
56
|
|
Other prepayments
|
154
|
116
|
|
VAT, sales tax, and other taxation
|
22
|
16
|
|
Miscellaneous receivables
|
16
|
10
|
|
Interest receivable
|
1
|
2
|
|
Collateral
|
2
|
–
|
|
Deferred divestment receivables
|
0
|
–
|
|
Derivative financial instruments
|
Note 29
|
–
|
2
|
Current other receivables
|
265
|
202
|
Note 26 – Cash and cash equivalents | |||
2024
|
2023
|
||
Deposits
|
417
|
649
|
|
Cash and bank balances
|
537
|
486
|
|
Total cash and cash equivalents in the consolidated statement | |||
of financial position
|
954
|
1,135
|
|
Minus: Bank overdrafts used
for cash management purposes
|
Note 28
|
(9)
|
(146)
|
Total cash and cash equivalents
minus bank overdrafts
|
945
|
989
|
Note 27 – Trade and other payables | |||
2024
|
2023
|
||
Trade payables
|
159
|
165
|
|
Salaries, holiday allowances,
and other benefits
|
326
|
285
|
|
VAT, sales tax, social security
premiums, and other taxation
|
99
|
91
|
|
Pension-related payables
|
32
|
28
|
|
Royalty payables
|
104
|
87
|
|
Other accruals and payables
|
311
|
295
|
|
Interest payable
|
51
|
42
|
|
Deferred and contingent acquisition payables
|
Note 29
|
2
|
4
|
Derivative financial instruments
|
Note 29
|
3
|
–
|
Total
|
1,087
|
997
|
Nominal | |||||||
Effective | interest | Repayment | Repayment | ||||
in millions of euros, unless | Nominal | interest | rate in | commitments | commitments | ||
otherwise stated | value | rate in % | % | 1-5 years |
>5 years
|
2024
|
2023
|
Bonds 2008-2028 (100.00
*
)
|
€36
|
6.812
|
6.748
|
36
|
–
|
36
|
36
|
Bonds 2017-2027 (99.659
*
)
|
€500
|
1.575
|
1.500
|
499
|
–
|
499
|
499
|
Bonds 2020-2030 (99.292
*
)
|
€500
|
0.862
|
0.750
|
–
|
497
|
497
|
496
|
Bonds 2021-2028 (99.958
*
)
|
€500
|
0.307
|
0.250
|
499
|
–
|
499
|
499
|
Bonds 2022-2026 (99.922
*
)
|
€500
|
3.096
|
3.000
|
499
|
–
|
499
|
499
|
Bonds 2023-2031 (99.417
*
)
|
€700
|
3.877
|
3.750
|
–
|
695
|
695
|
694
|
Bonds 2024-2029 (99.964
*
)
|
€600
|
3.316
|
3.250
|
599
|
–
|
599
|
–
|
Bonds, measured at
amortized cost
|
2,132
|
1,192
|
3,324
|
2,723
|
|||
Private placements | |||||||
2008-2038, measured at
amortized
cost
|
–
|
122
|
122
|
127
|
|||
Deferred and contingent | |||||||
acquisition payables,
measured at fair value
|
0
|
–
|
0
|
1
|
|||
Other debt, measured
at
amortized cost
|
21
|
–
|
21
|
21
|
|||
Derivative financial | |||||||
instruments, measured | |||||||
at fair
value
**
|
–
|
17
|
17
|
5
|
|||
Other long-term debt
|
21
|
17
|
38
|
27
|
|||
Total long-term debt | |||||||
(excluding lease liabilities)
|
2,153
|
1,331
|
3,484
|
2,877
|
|||
Lease liabilities
***
|
179
|
209
|
|||||
Total long-term debt
|
3,663
|
3,086
|
Reconciliation long-term debt to net debt | |||
2024
|
2023
|
||
Total long-term debt
|
3,663
|
3,086
|
|
Borrowings and bank overdrafts: | |||
Euro Commercial Paper program
|
350
|
50
|
|
Bank overdrafts, measured
at amortized cost
|
Note 26
|
9
|
146
|
Total borrowings and bank overdrafts
|
359
|
196
|
|
Bonds 2014-2024
|
–
|
400
|
|
Short-term lease liabilities
|
63
|
63
|
|
Deferred and contingent acquisition payables measured | |||
at fair value
|
Note 29
|
2
|
4
|
Derivative financial instruments
|
Note 29
|
3
|
–
|
Total short-term debt
|
427
|
663
|
|
Gross debt
|
4,090
|
3,749
|
|
Minus: | |||
Cash and cash equivalents
|
Note 26
|
(954)
|
(1,135)
|
Collateral
|
(2)
|
–
|
|
Deferred divestment consideration receivable
|
Note 8
|
0
|
–
|
Derivative financial instruments: | |||
Non-current assets
|
Note 21
|
–
|
–
|
Current assets
|
Note 25
|
–
|
(2)
|
Net debt
|
3,134
|
2,612
|
Gross debt, excluding lease liabilities, derivative financial instruments, and bank overdrafts | |||||||
Balance at | Foreign | Other | Balance at | ||||
January 1, | Net cash | Acquisitions/ | Unwinding | exchange | non-cash | December | |
2024 | flows | Divestments | of discount | differences | movements | 31, 2024 | |
Bonds
|
3,123
|
200
|
–
|
3
|
–
|
(2)
|
3,324
|
Private | |||||||
placements
|
127
|
–
|
–
|
–
|
(5)
|
–
|
122
|
Other gross debt
|
76
|
299
|
(3)
|
–
|
1
|
–
|
373
|
Total
|
3,326
|
499
|
(3)
|
3
|
(4)
|
(2)
|
3,819
|
Balance at | Foreign | Other | Balance at | ||||
January 1, | Net cash | Acquisitions/ | Unwinding | exchange | non-cash | December | |
2023 | flows | Divestments | of discount | differences | movements | 31, 2023 | |
Bonds
|
3,126
|
(4)
|
–
|
3
|
–
|
(2)
|
3,123
|
Private | |||||||
placements
|
142
|
–
|
–
|
0
|
(15)
|
–
|
127
|
Other gross debt
|
20
|
55
|
1
|
–
|
0
|
–
|
76
|
Total
|
3,288
|
51
|
1
|
3
|
(15)
|
(2)
|
3,326
|
Lease liabilities | |||
current and non current
|
2024
|
2023
|
|
Position at January 1
|
272
|
313
|
|
Additions from new leases
|
23
|
27
|
|
Acquired through business combinations
|
4
|
0
|
|
Contract modifications and reassessments
of options
|
(4)
|
4
|
|
Repayment of lease liabilities
(interest and principal portion)
|
(70)
|
(74)
|
|
Unwinding of discount of lease liabilities
|
Note 14
|
8
|
9
|
Foreign exchange differences
|
9
|
(7)
|
|
Position at December 31
|
Note 19
|
242
|
272
|
2024 | |
2026
|
510
|
2027
|
509
|
2028
|
535
|
2029
|
599
|
Due after 2029
|
1,331
|
Long-term debt
|
3,484
|
Short-term debt (2025)
|
364
|
Total (excluding lease liabilities)
|
3,848
|
2024
|
2023
|
|
Revenues
|
(40)
|
(38)
|
Adjusted operating profit
|
(14)
|
(13)
|
Operating profit
|
(13)
|
(12)
|
Adjusted net profit
|
(12)
|
(8)
|
Profit for the year
|
(11)
|
(8)
|
Shareholders’ equity at December
31
|
(29)
|
(36)
|
Adjusted free cash flow
|
(12)
|
(11)
|
Exchange | Interest | ||||
in millions, unless | Type of | rate movement | rate movement | ||
otherwise stated
|
Hedged risk
|
Amount
|
instrument | € | € |
Changes in ¥ floating | Cross-currency | ||||
interest payments and | interest | ||||
Cash flow hedge |
¥ exchange rates
|
¥20,000
|
rate swaps
|
(1)
|
0
|
Changes of the U.S. dollar | |||||
net investments due to | |||||
Net investment | fluctuations of U.S. dollar | Forward | |||
hedge |
exchange rates
|
$300
|
contracts 3 0 |
Contractual cash flows 2024 | Contractual cash flows 2023 | ||||||||||||
Contractual | Less | More | Contractual | Less | More | ||||||||
Carrying | undiscounted | than | 1-2 | 2-5 | than | Carrying | undiscounted | than | 1-2 | 2-5 | than | ||
Non-derivative financial liabilities | amount | cash flows | 1 year | years | years | 5 years | Non-derivative financial liabilities | amount | cash flows | 1 year | years | years | 5 years |
(excl. lease liabilities) | (excl. lease liabilities) | ||||||||||||
Bonds: | Bonds: | ||||||||||||
Bonds 2008-2028
|
36
|
45
|
2
|
2
|
41
|
–
|
Bonds 2008-2028
|
36
|
47
|
2
|
2
|
43
|
–
|
Bonds 2017-2027
|
499
|
524
|
8
|
8
|
508
|
–
|
Bonds 2014-2024
|
400
|
410
|
410
|
–
|
–
|
–
|
Bonds 2020-2030
|
497
|
523
|
4
|
4
|
11
|
504
|
Bonds 2017-2027
|
499
|
531
|
8
|
8
|
515
|
–
|
Bonds 2021-2028
|
499
|
505
|
1
|
1
|
503
|
–
|
Bonds 2020-2030
|
496
|
527
|
4
|
4
|
11
|
508
|
Bonds 2022-2026
|
499
|
530
|
15
|
515
|
–
|
–
|
Bonds 2021-2028
|
499
|
506
|
1
|
1
|
504
|
–
|
Bonds 2023-2031
|
695
|
884
|
26
|
26
|
79
|
753
|
Bonds 2022-2026
|
499
|
545
|
15
|
15
|
515
|
–
|
Bonds 2024-2029
|
599
|
699
|
20
|
20
|
659
|
–
|
Bonds 2023-2031
|
694
|
910
|
26
|
26
|
79
|
779
|
Private placements: | Private placements: | ||||||||||||
Private placements 2008-2038
|
122
|
177
|
4
|
4
|
12
|
157
|
Private placements 2008-2038
|
127
|
189
|
4
|
4
|
13
|
168
|
Long- and short-term deferred and | Long- and short-term deferred and | ||||||||||||
contingent acquisition payables
|
2
|
2
|
2
|
0
|
–
|
–
|
contingent acquisition payables
|
5
|
5
|
4
|
1
|
–
|
–
|
Other debt
|
21
|
21
|
–
|
11
|
10
|
–
|
Other debt
|
21
|
21
|
–
|
11
|
10
|
–
|
Borrowings and bank overdrafts
|
359
|
359
|
359
|
–
|
–
|
–
|
Borrowings and bank overdrafts
|
196
|
196
|
196
|
–
|
–
|
–
|
Trade payables
|
159
|
159
|
159
|
–
|
–
|
–
|
Trade payables
|
183
|
183
|
183
|
–
|
–
|
–
|
Total
|
3,987
|
4,428
|
600
|
591
|
1,823
|
1,414
|
Total
|
3,655
|
4,070
|
853
|
72
|
1,690
|
1,455
|
Derivative financial instruments | Derivative financial instruments | ||||||||||||
(Receipts)
(286)
|
(286)
|
(Receipts)
|
(252)
|
(252)
|
|||||||||
Payments
|
281
|
281
|
Payments
|
249
|
249
|
||||||||
Foreign exchange derivatives
|
3
|
(5)
|
(5)
|
0
|
0
|
0
|
Foreign exchange derivatives
|
(2)
|
(3)
|
(3)
|
0
|
0
|
0
|
(Receipts)
|
(177)
|
(4)
|
(4)
|
(12)
|
(157)
|
(Receipts)
|
(189)
|
(4)
|
(4)
|
(13)
|
(168)
|
||
Payments
|
230
|
8
|
8
|
23
|
191
|
Payments
|
238
|
8
|
8
|
23
|
199
|
||
Cross-currency interest
rate swaps
|
17
|
53
|
4
|
4
|
11
|
34
|
Cross-currency interest
rate swaps
|
5
|
49
|
4
|
4
|
10
|
31
|
Total derivative financial liabilities/(assets)
|
20
|
48
|
(1)
|
4
|
11
|
34
|
Total derivative financial liabilities/(assets)
|
3
|
46
|
1
|
4
|
10
|
31
|
2024
|
2023
|
||||||
Non-derivative financial instruments: |
Carrying value
|
Fair value
|
Level 1
|
Level 2
|
Level 3
|
Carrying value
|
Fair value
|
Financial assets at fair value
through profit or loss
|
0
|
0
|
0
|
0
|
0
|
||
Unbilled revenues
*
|
80
|
80
|
97
|
97
|
|||
Trade receivables
*
|
1,129
|
1,129
|
1,087
|
1,087
|
|||
VAT, sales tax, and other taxation
*
|
22
|
22
|
16
|
16
|
|||
Miscellaneous receivables
*
|
16
|
16
|
10
|
10
|
|||
Interest receivable
*
|
1
|
1
|
2
|
2
|
|||
Deferred divestment consideration receivable
*
|
0
|
0
|
–
|
–
|
|||
Cash and cash equivalents
*
|
954
|
954
|
1,135
|
1,135
|
|||
Total non-derivative financial
assets
|
2,202
|
2,202
|
0
|
2,347
|
2,347
|
||
Bonds 2008-2028
|
36
|
40
|
40
|
36
|
41
|
||
Bonds 2014-2024
|
–
|
–
|
400
|
398
|
|||
Bonds 2017-2027
|
499
|
487
|
487
|
499
|
479
|
||
Bonds 2020-2030
|
497
|
444
|
444
|
496
|
435
|
||
Bonds 2021-2028
|
499
|
462
|
462
|
499
|
449
|
||
Bonds 2022-2026
|
499
|
501
|
501
|
499
|
501
|
||
Bonds 2023-2031
|
695
|
723
|
723
|
694
|
727
|
||
Bonds 2024-2029
|
599
|
609
|
609
|
||||
Private placements 2008-2038
|
122
|
140
|
140
|
127
|
149
|
||
Long- and short-term deferred and contingent acquisition payables
|
2
|
2
|
2
|
5
|
5
|
||
Other debt
*
|
21
|
21
|
21
|
21
|
|||
Borrowings and bank overdrafts
*
|
359
|
359
|
196
|
196
|
|||
Trade payables
*
|
159
|
159
|
183
|
183
|
|||
Interest payable
*
|
51
|
51
|
42
|
42
|
|||
Total non-derivative financial
liabilities
|
4,038
|
3,998
|
3,266
|
140
|
2
|
3,697
|
3,626
|
Derivative financial instruments: | |||||||
Non-current assets
|
–
|
–
|
–
|
–
|
|||
Current assets
|
–
|
–
|
2
|
2
|
|||
Total derivative financial assets
|
0
|
0
|
2
|
2
|
|||
Non-current liabilities
|
17
|
17
|
17
|
5
|
5
|
||
Current liabilities
|
3
|
3
|
3
|
–
|
–
|
||
Total derivative financial liabilities
|
20
|
20
|
20
|
5
|
5
|
2024
|
2023
|
||
Balance at January 1
|
5
|
4
|
|
Acquired through business combinations
|
Note 8
|
0
|
4
|
Settlements
|
Note 8
|
(3)
|
(3)
|
Fair value changes of contingent considerations
|
Note 11
|
0
|
0
|
Foreign exchange differences
|
0
|
0
|
|
Balance at December 31
|
2
|
5
|
Fair value | Maximum | Fair value | |||
December 31, | Of which: | Of which: | exposure | December 31, | |
2024 | short term | long term | (undiscounted) | 2023 | |
Total
|
2
|
2
|
0
|
2
|
5
|
Note 30 – Employee benefits | ||
2024
|
2023
|
|
Retirement plans
|
11
|
29
|
Other post-employment benefit plans
|
47
|
45
|
Other long-term employment benefits
|
9
|
7
|
Total
|
67
|
81
|
Characteristics of material plans | |||
Retirement plans |
The Netherlands
|
United States
|
United Kingdom
|
Type of benefits
|
Pensions
|
Pensions
|
Pensions
|
Type of plan
|
Career average
|
Final salary
|
Final salary
|
Status of plan
|
Open
|
Frozen
|
Frozen
|
Service costs
|
Yes
|
No
|
No
|
Status of plan funding
|
Funded
|
Funded
|
Funded
|
Other post-employment plans | Post-retirement | ||
Type of benefits | medical plan | ||
Annual insurance | |||
Type of plan | premium coverage | ||
Status of plan
|
Closed
|
||
Service costs
|
Yes
|
||
Status of plan funding
|
Unfunded
|
in %
|
2024
|
2023
|
Retirement plans | ||
Discount rate to discount the
obligations at year end
|
3.6
|
3.3
|
Discount rate for pension expense
|
3.3
|
3.9
|
Expected rate of pension
increases (in payment) at
year end
|
3.1
|
2.6
|
Expected rate of pension
increases (in deferral)
at year end
|
3.1
|
2.5
|
Expected rate of inflation
increase for pension expense
|
2.2
|
2.1
|
Other post-employment benefit plans | ||
Discount rate to discount the
obligations at year end
|
4.8
|
4.3
|
Discount rate for pension expense
|
4.3
|
4.6
|
Medical cost trend rate
|
3.0
|
3.0
|
in years
|
The Netherlands
|
United States
|
United Kingdom
|
Life expectancy at
age of 65 now – Male
|
21.9
|
20.7
|
21.5
|
Life expectancy at
age of 65 now – Female
|
24.3
|
22.6
|
23.6
|
Life expectancy aged
65 in 20 years – Male
|
23.9
|
22.8
|
22.5
|
Life expectancy aged
65 in 20 years – Female
|
26.3
|
25.1
|
25.0
|
Sensitivity retirement plans | ||||
Gross service cost | ||||
(excluding interest)
|
Defined benefit obligations
|
|||
2024
|
Baseline
|
17
|
1,369
|
|
Decrease of | Increase of | Decrease of | Increase of | |
Change compared to baseline | assumption | assumption | assumption | assumption |
Discount rate (change by 1%)
|
6
|
(4)
|
240
|
(189)
|
Pension increase rate (change
by 0.5%)
|
(2)
|
2
|
(93)
|
104
|
Inflation increase rate
(change by 0.5%)
|
(2)
|
3
|
(129)
|
151
|
Mortality table (change by one year)
|
–
|
0
|
(66)
|
57
|
Sensitivity of the defined benefit obligations (DBO) of retirement plans in the consolidated | |||||
statement of financial position and the defined benefit expense of the retirement plans | |||||
in the consolidated statement of profit or loss (P&L) |
The Netherlands
|
United States
|
United Kingdom
|
||
DBO
|
P&L
|
DBO
|
P&L
|
DBO
|
P&L
|
Discount rate sensitivity |
–
|
–
|
|||
Pension increase sensitivity |
–
|
–
|
–
|
||
Inflation rate sensitivity |
–
|
–
|
–
|
||
Mortality sensitivity |
–
|
–
|
Sensitivity of other post-employment plans | |||
Gross service costs | |||
in millions of euro |
(excluding interest)
|
Defined benefit obligations
|
|
2024
|
Baseline
|
1
|
47
|
Change compared to baseline | |||
Discount rate (by -1%)
|
0
|
4
|
|
Discount rate (by +1%)
|
0
|
(3)
|
Defined benefit | Other post- | |||||||||
Plan liabilities and plan assets | retirement plans | employment plans | ||||||||
Defined benefit | Other post- |
2024
|
2023
|
2024
|
2023
|
|||||
retirement plans | employment plans | Pension expenses | ||||||||
2024
|
2023
|
2024
|
2023
|
Employer service cost
|
15
|
13
|
1
|
1
|
||
Plan liabilities |
Past service costs
– plan amendment
|
(27)
|
–
|
–
|
–
|
|||||
Fair value at January 1
|
1,352
|
1,263
|
45
|
44
|
Interest expense on
irrecoverable surplus
|
0
|
0
|
–
|
–
|
|
Employer service cost
|
15
|
13
|
1
|
1
|
Interest expense on
defined benefit obligations
|
44
|
48
|
2
|
2
|
|
Interest expense on
defined benefit obligations
|
44
|
48
|
2
|
2
|
Interest income on plan assets
|
(44)
|
(47)
|
–
|
–
|
|
Administration costs
and taxes
|
2
|
2
|
–
|
–
|
Administration costs
and taxes
|
2
|
2
|
–
|
0
|
|
Benefits paid by fund
|
(55)
|
(54)
|
–
|
–
|
Total pension expense
|
(10)
|
16
|
3
|
3
|
|
Benefits paid by employer
|
–
|
–
|
(3)
|
(3)
|
Of which is included in: | |||||
Remeasurement (gains)/losses
|
25
|
78
|
0
|
2
|
Employee benefit expenses
|
Note 12
|
(11)
|
15
|
1
|
1
|
Acquired through business combinations
|
1
|
–
|
0
|
0
|
Other finance (income)/costs
|
Note 14
|
1
|
1
|
2
|
2
|
Contributions by plan participants
|
4
|
4
|
–
|
–
|
||||||
Plan amendments and curtailments
|
(27)
|
–
|
–
|
–
|
||||||
Foreign exchange differences
|
8
|
(2)
|
2
|
(1)
|
||||||
Fair value at December 31
|
1,369
|
1,352
|
47
|
45
|
||||||
Plan assets | ||||||||||
Fair value at January 1
|
1,337
|
1,240
|
0
|
0
|
||||||
Interest income on plan assets
|
44
|
47
|
–
|
–
|
||||||
Return on plan assets
greater than discount rate
|
6
|
82
|
–
|
–
|
||||||
Benefits paid by fund
|
(55)
|
(54)
|
(3)
|
(3)
|
||||||
Acquired through business combinations
|
1
|
–
|
–
|
–
|
||||||
Contributions by employer
|
13
|
19
|
3
|
3
|
||||||
Contributions by plan participants
|
4
|
4
|
–
|
–
|
||||||
Foreign exchange differences
|
8
|
(1)
|
–
|
–
|
||||||
Fair value at December 31
|
1,358
|
1,337
|
0
|
0
|
||||||
Funded status | ||||||||||
Deficit/(surplus) at December
31
|
11
|
15
|
47
|
45
|
||||||
Irrecoverable surplus
|
0
|
14
|
–
|
–
|
||||||
Net liability at December
31
|
11
|
29
|
47
|
45
|
2024
|
2023
|
|
Position at January 1
|
(121)
|
(120)
|
Recognized in other comprehensive income
|
(5)
|
(1)
|
Cumulative amount at December
31
|
(126)
|
(121)
|
Remeasurement gains/(losses) for the year | ||
2024
|
2023
|
|
Remeasurement gains/(losses) due to experience
adjustments
|
16
|
(62)
|
Remeasurement gains/(losses)
due to changes in demographic assumptions
|
3
|
3
|
Remeasurement gains/(losses)
due to changes in financial assumptions
|
(44)
|
(21)
|
Remeasurement gains/(losses)
on defined benefit obligations
|
(25)
|
(80)
|
Return on plan assets
greater/(lower) than discount
rate
|
6
|
82
|
Change in irrecoverable surplus, other than interest and foreign | ||
exchange differences
|
14
|
(3)
|
Recognized remeasurement
gains/(losses) on defined benefit
plans in other
comprehensive income
|
(5)
|
(1)
|
number of years
|
2024
|
2023
|
Retirement plans | ||
The Netherlands
|
16.5
|
16.7
|
United Kingdom
|
10.7
|
11.5
|
United States
|
8.7
|
9.3
|
Other post-employment plans | ||
United States
|
6.3
|
6.7
|
Equity |
2024
|
Quoted
|
Unquoted
|
2023
|
Quoted
|
Unquoted
|
Equity
|
392
|
392
|
–
|
355
|
355
|
–
|
Private equity
|
1
|
–
|
1
|
1
|
–
|
1
|
Bonds | ||||||
Government bonds
|
396
|
396
|
–
|
476
|
476
|
–
|
Corporate bonds
|
177
|
177
|
–
|
183
|
183
|
–
|
Other bonds
|
–
|
–
|
–
|
11
|
11
|
–
|
Asset-backed securities
|
111
|
111
|
–
|
87
|
87
|
–
|
Other
Insurance contracts
|
205
|
77
|
128
|
130
|
–
|
130
|
Real estate
|
97
|
45
|
52
|
93
|
42
|
51
|
Derivatives and other
securities
|
(27)
|
(27)
|
–
|
(20)
|
(20)
|
–
|
Cash
|
6
|
6
|
–
|
21
|
21
|
–
|
Total
|
1,358
|
1,177
|
181
|
1,337
|
1,155
|
182
|
Proportion of plan assets | ||
in %
|
2024
|
2023
|
Equity
|
29
|
27
|
Bonds
|
50
|
57
|
Other
|
21
|
16
|
Total
|
100
|
100
|
Note 31 – Provisions | ||
2024
|
2023
|
|
Provision for restructuring commitments
|
15
|
7
|
Provision for acquisition integration
|
1
|
1
|
Restructuring provisions
|
16
|
8
|
Legal provisions
|
11
|
12
|
Other provisions
|
6
|
6
|
Total
|
33
|
26
|
Of which short term
|
28
|
21
|
Movements in provisions | ||||||
Restructuring | Legal | Other | ||||
Long-term provisions at | provisions | provisions |
provisions
|
2024
|
2023
|
|
January 1
|
0
|
1
|
4
|
5
|
5
|
|
Add: short-term provisions
|
8
|
11
|
2
|
21
|
19
|
|
Total provisions at
January 1
|
8
|
12
|
6
|
26
|
24
|
|
Movements | ||||||
Additions for restructuring | ||||||
of stranded costs
|
Note 8
|
1
|
–
|
–
|
1
|
0
|
Additions for acquisition | ||||||
integration
|
Note 11
|
0
|
–
|
–
|
0
|
4
|
Other additions
|
16
|
1
|
1
|
18
|
10
|
|
Total additions
|
17
|
1
|
1
|
19
|
14
|
|
Appropriation of provisions
|
(7)
|
(2)
|
0
|
(9)
|
(10)
|
|
Release of provisions
|
(2)
|
(1)
|
(2)
|
(5)
|
(2)
|
|
Exchange differences
|
1
|
1
|
0
|
2
|
0
|
|
Total movements
|
9
|
(1)
|
(1)
|
7
|
2
|
|
Total provisions at
December 31
|
17
|
11
|
5
|
33
|
26
|
|
Less: short-term provisions
|
(16)
|
(9)
|
(3)
|
(28)
|
(21)
|
|
Long-term provisions at
December 31
|
1
|
2
|
2
|
5
|
5
|
Number of shares | ||||||
Number of | Minus: number of | Total number of ordinary | ||||
ordinary shares | treasury shares | shares outstanding | ||||
in thousands of shares, unless | ||||||
otherwise stated
|
2023
|
2024
|
2024
|
2023
|
2024
|
2023
|
At January 1
|
257,516
|
248,516
|
(8,005)
|
(8,802)
|
240,511
|
248,714
|
Cancelation of shares
|
(9,000)
|
(10,000)
|
10,000
|
9,000
|
0
|
0
|
Repurchased shares
|
–
|
–
|
(6,701)
|
(8,738)
|
(6,701)
|
(8,738)
|
Long-term incentive plan
|
–
|
–
|
556
|
535
|
556
|
535
|
At December 31
|
248,516
|
238,516
|
(4,150)
|
(8,005)
|
234,366
|
240,511
|
Issued share capital at €0.12 (€’000)
|
29,822
|
28,622
|
||||
Proposed dividend per share
(€)
|
2.33
|
2.08
|
||||
Proposed dividend distribution | ||||||
(€’000)
|
547,818
|
502,722
|
Dividend distributions over financial year | |||
2024
|
2023
|
2022
|
|
Originally proposed dividend
over financial year
|
548
|
503
|
453
|
Actual payments: | |||
Interim dividend (paid in the financial
year)
|
196
|
176
|
160
|
Final dividend (paid in the subsequent
financial year)
|
324
|
291
|
|
Total dividend distribution
|
500
|
451
|
Note 33 – Share-based payments | ||
2024
|
2023
|
|
Long-term incentive plan
|
27
|
29
|
Restricted Stock Units
|
4
|
2
|
Total equity-settled share-based payments
|
31
|
31
|
Fair value of Adjusted EPS and | Fair value TSR shares | |
in euros | ROIC shares at grant date | at grant date |
LTIP 2024-26
|
121.35
|
86.87
|
LTIP 2023-25
|
91.37
|
68.72
|
LTIP 2022-24
|
97.82
|
71.71
|
LTIP 2021-23
|
64.06
|
47.03
|
LTIP 2021-23: number of shares vested and the cash equivalent thereof | ||||||
Increase in | Increase in | Increase in | Payout/ | |||
conditional | conditional | conditional | vested | |||
number of shares, | Outstanding | number of | number of | number of | shares | Cash value |
unless otherwise | at December | EPS shares | ROIC shares | TSR shares | February 22, | vested |
stated | 31, 2023 | (50%) | (50%) | (25%) | 2024 |
shares
*
|
Executive Board
|
93,503
|
11,876
|
7,918
|
13,480
|
126,777
|
18,656
|
Senior management
|
303,256
|
45,564
|
30,408
|
37,944
|
417,172
|
61,388
|
Total
|
396,759
|
57,440
|
38,326
|
51,424
|
543,949
|
80,044
|
LTIP 2022-24 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
number of shares
|
Total
|
condition | condition | condition |
Conditionally awarded grant 2022
|
303,253
|
88,324
|
58,886
|
156,043
|
Forfeited in previous years
|
(19,773)
|
(5,930)
|
(3,953)
|
(9,890)
|
Shares outstanding at January
1, 2024
|
283,480
|
82,394
|
54,933
|
146,153
|
Forfeited during the year
|
(26,736)
|
(8,021)
|
(5,349)
|
(13,366)
|
Effect of 145% vesting – EPS-performance
|
33,469
|
33,469
|
–
|
–
|
Effect of 150% vesting – ROIC-performance
|
24,864
|
–
|
24,864
|
–
|
Effect of 125% vesting – TSR-ranking
|
33,222
|
–
|
–
|
33,222
|
Vested at December 31, 2024
|
348,299
|
107,842
|
74,448
|
166,009
|
LTIP 2023-25 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
base number of shares at 100% payout
|
Total
|
condition | condition | condition |
Conditionally awarded grant 2023
|
338,699
|
98,605
|
65,708
|
174,386
|
Forfeited in previous years
|
(989)
|
(297)
|
(198)
|
(494)
|
Shares outstanding at January
1, 2024
|
337,710
|
98,308
|
65,510
|
173,892
|
Forfeited during the year
|
(33,494)
|
(10,034)
|
(6,687)
|
(16,773)
|
Shares outstanding at December
31, 2024
|
304,216
|
88,274
|
58,823
|
157,119
|
LTIP 2024-26 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
base number of shares at 100% payout
|
Total
|
condition | condition | condition |
Conditionally awarded grant 2024
|
263,249
|
76,193
|
50,764
|
136,292
|
Forfeited during the year
|
(7,362)
|
(2,209)
|
(1,472)
|
(3,681)
|
Shares outstanding at December
31, 2024
|
255,887
|
73,984
|
49,292
|
132,611
|
Overview of outstanding performance shares: LTIP 2023-25 and LTIP 2024-26 | |||
base numbers of shares at 100%
payout
|
LTIP 2023-25
|
LTIP 2024-26
|
Total
|
Conditionally awarded grant 2023
|
338,699
|
–
|
338,699
|
Forfeited in previous years
|
(989)
|
–
|
(989)
|
Shares outstanding at January
1, 2024
|
337,710
|
0
|
337,710
|
Conditionally awarded grant 2024
|
–
|
263,249
|
263,249
|
Forfeited during the year
|
(33,494)
|
(7,362)
|
(40,856)
|
Shares outstanding at December
31, 2024
|
304,216
|
255,887
|
560,103
|
Fair value | Fair value | Fair value | |
RSU shares | RSU shares | RSU shares | |
at grant date | at grant date | at grant date | |
in euros | March 1 | July 1 | November 1 |
RSU shares 2023 – one-year vesting
period
|
107.56
|
114.26
|
118.96
|
RSU shares 2023 – two-years
vesting period
|
105.46
|
111.98
|
116.55
|
RSU shares 2023 – three-years
vesting period
|
103.11
|
109.43
|
113.86
|
RSU shares 2024 – one-year vesting
period
|
143.68
|
152.45
|
152.22
|
RSU shares 2024 – two-years vesting
period
|
141.25
|
149.83
|
149.43
|
RSU shares 2024 – three-years
vesting period
|
138.72
|
146.88
|
146.30
|
Overview of outstanding performance shares | ||||
Grant date | Grant date | Grant date | ||
Conditionally awarded number of RSU shares, | Total number | March 1, | July 1, | November 1, |
grant 2023 | of RSU shares | 2023 | 2023 | 2023 |
One-year vesting period
|
12,873
|
11,951
|
333
|
589
|
Two-years vesting period
|
12,845
|
11,924
|
332
|
589
|
Three-years vesting period
|
12,752
|
11,832
|
332
|
588
|
Total shares conditionally awarded
|
38,470
|
35,707
|
997
|
1,766
|
Forfeitures during the year 2023
|
(928)
|
(928)
|
–
|
–
|
Shares outstanding at December
31, 2023
|
37,542
|
34,779
|
997
|
1,766
|
Forfeitures during the year 2024
|
(1,043)
|
(1,043)
|
–
|
–
|
Vesting in 2024
|
(12,516)
|
(11,594)
|
(333)
|
(589)
|
Shares outstanding at December
31, 2024
|
23,983
|
22,142
|
664
|
1,177
|
Grant date | Grant date | Grant date | ||
Conditionally awarded number of RSU shares, | Total number | March 1, | July 1, | November 1, |
grant 2024 | of RSU shares | 2024 | 2024 | 2024 |
One-year vesting period
|
11,678
|
10,701
|
323
|
654
|
Two-years vesting period
|
11,549
|
10,575
|
323
|
651
|
Three-years vesting period
|
11,451
|
10,477
|
323
|
651
|
Total shares conditionally awarded
|
34,678
|
31,753
|
969
|
1,956
|
Forfeitures during the year
|
(1,137)
|
(1,137)
|
–
|
–
|
Shares outstanding at December
31, 2024
|
33,541
|
30,616
|
969
|
1,956
|
Total number | RSU grant in | RSU grant in | |
Total conditionally awarded number of RSU shares | of RSU shares | 2023 | 2024 |
RSU shares outstanding at January
1, 2023
|
–
|
–
|
–
|
Conditionally awarded in 2023
|
38,470
|
38,470
|
–
|
Forfeitures during the year 2023
|
(928)
|
(928)
|
–
|
RSU shares outstanding at January
1, 2024
|
37,542
|
37,542
|
–
|
Condionally awarded in 2024
|
34,678
|
34,678
|
|
Forfeitures during the year 2024
|
(2,180)
|
(1,043)
|
(1,137)
|
Vesting in 2024
|
(12,516)
|
(12,516)
|
–
|
Shares outstanding at December
31, 2024
|
57,524
|
23,983
|
33,541
|
Audit fees 2024 | |||
Other Deloitte | |||
Deloitte | member firms and | ||
Accountants B.V. |
affiliates
|
Total Deloitte
|
|
Statutory audit of annual accounts
|
1.2
|
2.2
|
3.4
|
CSRD limited assurance
|
0.3
|
–
|
0.3
|
Other assurance services
|
0.1
|
0.3
|
0.4
|
Tax advisory services
|
–
|
0.0
|
0.0
|
Other non-audit services
|
0.0
|
0.1
|
0.1
|
Total
|
1.6
|
2.6
|
4.2
|
Audit fees 2023 | |||
Other Deloitte | |||
Deloitte | member firms and | ||
Accountants B.V. |
affiliates
|
Total Deloitte
|
|
Statutory audit of annual accounts
|
1.0
|
2.3
|
3.3
|
CSRD limited assurance
|
–
|
–
|
0.0
|
Other assurance services
|
0.1
|
0.3
|
0.4
|
Tax advisory services
|
–
|
0.0
|
0.0
|
Other non-audit services
|
–
|
0.0
|
0.0
|
Total
|
1.1
|
2.6
|
3.7
|
2024
|
2023
|
||
Parental performance guarantees
to third parties
|
5
|
5
|
|
Guarantee to the trustees
of the U.K. retirement
plan
|
Note 30
|
22
|
21
|
Real estate and other guarantees
|
10
|
11
|
|
Drawn bank credit facilities
|
1
|
1
|
|
Total
|
38
|
38
|
Remuneration Executive Board | ||||
The table below provides the total compensation of the Executive Board recognized in the | ||||
consolidated statement of profit or loss: | ||||
in thousands of euros
|
2024
|
2023
|
||
Fixed compensation: | ||||
Salary
|
2,387
|
2,308
|
||
Social security
|
234
|
247
|
||
Defined contribution plan
|
185
|
180
|
||
Other benefits
*
|
458
|
400
|
||
Total fixed compensation
|
3,264
|
3,135
|
||
Variable compensation: | ||||
STIP
|
2,998
|
2,736
|
||
LTIP
**
|
6,260
|
6,307
|
||
Total variable compensation
|
9,258
|
9,043
|
||
Sub-total fixed and variable compensation
|
12,522
|
12,178
|
||
Tax-related
costs
***
|
199
|
(459)
|
||
Total remuneration Executive
Board
|
12,721
|
11,719
|